Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares Broad USD Investment Grade Corporate Bond (USIG) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance

iShares Broad USD Investment Grade Corporate BondTrade
DENTSPLY SIRONA IncTrade

Price performance (Past 24H)

Key statistics

iShares Broad USD Investment Grade Corporate Bond vs DENTSPLY SIRONA Inc — how do they compare? iShares Broad USD Investment Grade Corporate Bond trades at $50.21, while DENTSPLY SIRONA Inc trades at $11.69 (market cap $2.32B). The key difference: DENTSPLY SIRONA Inc pays a 5.04% dividend while iShares Broad USD Investment Grade Corporate Bond pays none, and DENTSPLY SIRONA Inc is trading nearer its 52-week high, iShares Broad USD Investment Grade Corporate Bond nearer its low. Which is the better fit depends on your goals.

USIGXRAY
Sector
Fixed IncomeHealth
52-Week High
$52.69$14.68
52-Week Low
$50.18$9.64
Market Cap
$2.32B
Enterprise Value
$4.40B
Dividend Yield
5.04%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares Broad USD Investment Grade Corporate Bond

USIG trades at $50.40 with minimal daily movement (+0.16%). Technical indicators show a bearish bias with moving averages signaling caution, though oscillators remain neutral. The company maintains consistent dividend distributions, with recent payouts of $0.20-$0.21 per share. Recent news includes AM Best affirming credit ratings for subsidiaries following a transaction with Tiptree Inc.

Investment outlook remains cautious given bearish technical signals and limited fundamental data availability. The steady dividend history provides income appeal, but investors face uncertainty from incomplete financial metrics. Key risks include potential volatility from institutional positioning changes and transaction integration challenges with Tiptree.

DENTSPLY SIRONA Inc

DENTSPLY SIRONA (XRAY) trades at $12.12, down 7.97% in 24 hours, with a bearish technical signal and support near $12. The company reported Q2 2026 EPS of $0.52, beating expectations, but revenue declined 4.1% year-over-year. Financials show negative net income margins and ROE, though gross margins remain solid at 49.52%. Recent news highlights institutional stake increases and strategic partnerships, such as the expanded Medline Sinclair relationship in Canada.

The outlook is cautious due to persistent revenue declines and profitability challenges, offset by cost-cutting efforts and digital dentistry growth. Risks include weak European demand and high debt levels, while analyst consensus is Hold with a $11.50 price target, indicating limited near-term upside amid turnaround execution uncertainties.

Returns comparison

Trailing returns across standard periods

About iShares Broad USD Investment Grade Corporate Bond

USIG is a low-cost ETF providing broad exposure to over 11,000 U.S. investment-grade corporate bonds. It tracks the ICE BofA US Corporate Index, featuring high-quality debt from 2026 leaders like Citigroup, Bank of America, and Oracle.

Read more on USIG

About DENTSPLY SIRONA Inc

Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters

Read more on XRAY